Abstract

The transdermal route of administration of drug substances allows clinicians to obtain a therapeutic effect bypassing the gastrointestinal tract, where the active substance could be inactivated. The hormonal substance used in the study-corticotropin (ACTH)-shows systemic effects. Therefore, the study of the effect of the type of ointment base and drug concentration on the release rate and also permeation rate in in vivo simulated conditions may be a valuable source of information for clinical trials to effectively optimize corticotropin treatment. This goal was achieved by preparation ointment formulation selecting the appropriate ointment base and determining the effect of ACTH concentration on the release and permeation studies of the ACTH. Semi-solid preparations containing ACTH were prepared using Unguator CITO e/s. The release study of ACTH was tested using a modified USP apparatus 2 with Enhancer cells. The permeation study was conducted with vertical Franz cells. Rheograms of hydrogels were made with the use of a universal rotational rheometer. The dependence of the amount of released and permeated hormone on the ointment concentration was found. Based on the test of ACTH release from semi-solid formulations and evaluation of rheological parameters, it was found that glycerol ointment is the most favourable base for ACTH. The ACTH release and permeation process depends on both viscosity and ACTH concentration. The higher the hormone concentration, the higher the amount of released ACTH but it reduces the amount of ACTH penetrating through porcine skin.

Highlights

  • Corticotropin (ACTH) is a hormone secreted by the anterior pituitary gland

  • The modification of the composition of the hydrogel base used may allow obtaining a base for the controlled release of active substances from the formulations prepared [27,28,29,30,31,32]

  • Analyzing the results of ACTH release test it can be stated that the degree of ACTH release depends on several factors: the base used, the concentration of ACTH, rheological parameters of ointment

Read more

Summary

Introduction

Corticotropin (ACTH) is a hormone secreted by the anterior pituitary gland. It is a polypeptide consisting of 39 amino acid residues with a 4.5 kDa molecular weight [1,2,3]. It has 63 hydrogen donors and 68 hydrogen acceptors. Corticotropin has been used in medicine since 1952 in the form of injections. This hormone is an alternative treatment for multiple sclerosis in patients with or without corticosteroid intolerance. Exacerbation of multiple sclerosis as a result of stress may be caused by dysfunction of the hypothalamic-pituitary-adrenal axis (HPA) due to decreased

Objectives
Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.